Uncategorized
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership
The FDA in February briefly refused to review Moderna’s flu vaccine, citing trial inadequacies, but reversed course a few days later. A verdict is expected by Aug. 5. Read More